NHS England Rolls Out Evkeeza® ▼(Evinacumab) For Eligible Adults And Adolescents Aged 12 Years And Older With Homozygous Familial Hypercholesterolaemia (Hofh)

Published on December 20, 2024

plans and objectives, including its expectations regarding the market opportunities for Evkeeza are forward-looking statements within the